Originalpublikationen Augenklinik im Jahr 2006
1. Barthelmes D., Sutter F.K., Kurz-Levin M., Bösch M., Helbig H., Niemeyer G., Fleischhauer J.C.: Quantitative analysis of OCT characteristics in patients with achromatopsia and blue cone monochromatism Invest Ophthalmol Vis Sci 2006;47:1161-1166
2. Bemelmans A.P., Kostic C., Crippa S.V., Hauswirth W.H., Lem J., Seeliger M.W.,
Wenzel A., Arsenijevic Y.: Lentiviral vectors containing a retinal pigment epithelium specific promoter for Leber congenital amaurosis gene therapy. Lentiviral gene therapy for LCA Adv Exp Med Biol 2006;572:247-253
3. : Ophthalmologic findings and
long-term course in patients with neurofibromatosis type 2 Am J Ophthalmol 2006;141:1068-1077
meningiomas in patients with neurofibromatosis type 2 Arch Ophthalmol 2006;124:379-385
5. ., ., ., .,
.: Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene Graefe’s Arch Clin Exp Ophthalmol 2006;244:1104-1112
6. Flogel W., Widmeier S., Hotz P., Schärer L., Barthelmes D., Landau K., Thiel M.A.:
Corneal and conjunctival findings in systemic silver intoxication Klin Monatsbl Augenheilkd 2006;223:390-392
7. Frigg R., Wenzel A., Samardzija M., Oesch B., Wariwoda H., Reme C., Grimm
The Prion Protein is neuroprotective against retinal degeneration in vivo Exp Eye Res 2006;83:1350-1358
Sutter F.K., Simpson J.M., Larson J., Ali H., Zhu M.: Intravitreal
triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial
9. Gehrig A., Janssen A., Horling F., Grimm C., Weber B.H.F.: The role of caspases in
photoreceptor death of the retinoschisin-deficient mouse Cytogenet Genome Res 2006;115:35-44
10. Heimann H., Zou X., Jandeck C., Kellner U., Bechrakis N.E., Kreusel K.M., Helbig H.,
Krause L., Schüler A., Bornfeld N., Foerster M.H.: Primary vitrectomy for rhegmatogenous retinal detachment – an analysis of 512 cases
Graefe's Arch Clin Exp Ophthalmol 2006;244:68-78
11. Kaufmann C., Bachmann L.M., Robert Y.C., Thiel M.A.: Ocular pulse amplitude in
healthy subjects as measured by dynamic contour tonometryArch Ophthalmol 2006;124:1104-1108
12. Kniestedt C., Taralczak M., Thiel M.A., Stürmer J., Baumer A., Gloor B.P. A novel
PITX2 mutation and a polymorphism in a 5-generation family with Axenfeld-Rieger anomaly and co-existing Fuchs’ endothelial dystrophy Ophthalmology 2006;113:1791-1797
13. Marti S., Bockisch C.J., Straumann D.: Asymmetric short-term adaptation of the
vertical vestibulo-ocular reflex in humans
Exp Brain Res. 2006;172:343-350
14. Menke M.N., Feke G.T., McMeel J.W., Branagan A., Hunter Z., Treon S.P.:
Hyperviscosity-related retinopathy in Waldenstrom macroglobulinemia
15. Menke M.N., Kim E.C., Bula D.V., Bertram K.M., Arroyo J.G.: The question of
macular hole: avulsed epiretinal membrane shadowing artifact in optical coherence tomography testing
16. Monnerat N., Bossart W., Thiel M.A.: Povidone-iodine for treatment of adenoviral
conjunctivitis: an in vitro study Klin Monatsbl Augenheilkd 2006;223:349-352
17. Neidhardt J., Barthelmes D., Farahmand F., Fleischhauer J.C., Berger W.: Different
amino acid substitutions at the same position in rhodopsin lead to distinct phenotypesInvest Ophthalmol Vis Sci 2006;47:1630-1635
18. Palla A., Bockisch C.J., Bergamin O., Straumann D.: Dissociated hysteresis of static Neurophysiol 2006;95:2222-2232
19. Peter J., Piantadosi J., Piantadosi C., Cooper P., Gehling N., Kaufmann C., Goggin
M.: Use of real-time telemedicine in the detection of diabetic macular oedema: a pilot study
Clin Experiment Ophthalmol 2006;34:312-316
20. Pfenninger L., Landau K., Bergamin O.: Comparison of Harms tangent screen and
search coil recordings in patients with trochlear nerve palsy
21. Rohrer B., Demos C., Frigg R., Grimm C.: Classical complement activation and
acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse Exp Eye Res 2006;epub Oct 25
22. Samardzija M., Wenzel A., Naash M., Remé C., Grimm C.: Rpe65 as modifier gene
for inherited retinal degeneration Eur J Neurosci 2006;23:1028-1034
23. Samardzija M., Wenzel A., Aufenberg S., Thiersch M., Remé C., Grimm C.:
Differential role of Jak-STAT signaling in retinal degenerations FASEB J 2006;20:2411-2413
24. Samardzija M., Wenzel A., Thiersch M., Frigg R., Remé C., Grimm C.: Caspase-1
ablation protects photoreceptors in a model of autosomal dominant retinitis pigmentosa.
Invest Ophthalmol Vis Sci 2006;47:5181-5190
25. Sato E, Feke GT, Appelbaum EY, Menke MN, Trempe CL, McMeel JW.: Association
between systemic arterial stiffness and age-related macular degeneration Graefe’s Arch Clin Exp Ophthalmol 2006;255:963-971
26. Schröder-Frei B., Kurrer M., Chaloupka K., Frei J., Landau K.: Orbital MALT
lymphomas: clinicopathological correlation Klin Monatsbl Augenheilkd 2006;223:405-408
27. Sirimaharaj R., Robinson M.R., Zhu M., Csaky K.G., Donovan B., Sutter F.K., Gillies
M.C.: Intravitreal injection of triamcinolone acetonide for immune recovery uveitis
Sutter F. z-Levin M., Fleischhauer J.C., Bösch M., Barthelmes D., Helbig H.: Macular atrophy following combined triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP) Klin Monatsbl Augenheilkd 2006;223:376-378
29. Von Schulthess S., Kaufmann C., Bachmann L. C., Yanar A., Thiel MA.: Ocular Graefe’s Arch Clin Exp Ophthalmol
30. Widmer S., Helbig H.: Presumed macular toxicity of intravitreal antibiotics Klin Monatsbl Augenheilkd 2006;223:456-458
31. Wirth M.G., Helbig H.: Vitreous hemorrhage in children Klin Monatsbl Augenheilkd 2006;223:440-442
nden R., De Melo M., Trick A.J., Kovacs R., Thiel MA.: Risk of
bacterial contamination after povidone-iodine disinfection for cataract surgery Klin Monatsbl Augenheilkd 2006;223:357-360
Actos generales de la 64 Feria del Juguete International Toy Fair Nürnberg 2013 Fechas en el recinto ferial PressPreview – la presentación de novedades para la prensa Martes, 29.01.2013, 9.00-13.00 horas en el NCC Ost Antes del comienzo oficial de la Feria del Juguete, las empresas presentan con el apoyo de famosos y modelos sus novedades de productos con gran impacto visual para los medio
RLUH ICU: Guidelines for the Use of Steroids In ARDS in the ITU GUIDELINES FOR THE USE OF STEROIDS IN ARDS IN THE ITU Various regimens are described in the literature: 1. • Treatment commenced after 15 +/- 7.5 days • Methylprednisolone 200 mg bolus then: • 2–3 mgkg-1day-1 until extubated then taper over 6 weeks Refs: Meduri et al. Chest 1994; 105: 1516–1527 See also letter in